Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ANG LIFESCIENCES INDIA vs BLISS GVS PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ANG LIFESCIENCES INDIA BLISS GVS PHARMA ANG LIFESCIENCES INDIA/
BLISS GVS PHARMA
 
P/E (TTM) x -5.3 13.1 - View Chart
P/BV x 0.7 1.3 50.7% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 ANG LIFESCIENCES INDIA   BLISS GVS PHARMA
EQUITY SHARE DATA
    ANG LIFESCIENCES INDIA
Mar-23
BLISS GVS PHARMA
Mar-23
ANG LIFESCIENCES INDIA/
BLISS GVS PHARMA
5-Yr Chart
Click to enlarge
High Rs27691 302.1%   
Low Rs7267 107.0%   
Sales per share (Unadj.) Rs168.472.2 233.3%  
Earnings per share (Unadj.) Rs-0.27.4 -2.7%  
Cash flow per share (Unadj.) Rs7.09.2 76.0%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs66.084.0 78.6%  
Shares outstanding (eoy) m13.06104.15 12.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.01.1 94.0%   
Avg P/E ratio x-867.210.8 -8,054.6%  
P/CF ratio (eoy) x25.08.7 288.6%  
Price / Book Value ratio x2.60.9 279.1%  
Dividend payout %06.8 -0.0%   
Avg Mkt Cap Rs m2,2728,262 27.5%   
No. of employees `000NANA-   
Total wages/salary Rs m240862 27.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,1997,516 29.3%  
Other income Rs m97178 54.7%   
Total revenues Rs m2,2967,694 29.8%   
Gross profit Rs m1471,173 12.6%  
Depreciation Rs m94187 50.1%   
Interest Rs m125104 120.4%   
Profit before tax Rs m261,061 2.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m29293 9.8%   
Profit after tax Rs m-3767 -0.3%  
Gross profit margin %6.715.6 42.9%  
Effective tax rate %110.027.7 397.7%   
Net profit margin %-0.110.2 -1.2%  
BALANCE SHEET DATA
Current assets Rs m1,8526,974 26.6%   
Current liabilities Rs m1,6231,933 84.0%   
Net working cap to sales %10.467.1 15.5%  
Current ratio x1.13.6 31.6%  
Inventory Days Days139 2.3%  
Debtors Days Days1,3801,871 73.8%  
Net fixed assets Rs m8874,562 19.4%   
Share capital Rs m131104 125.4%   
"Free" reserves Rs m7328,646 8.5%   
Net worth Rs m8628,750 9.9%   
Long term debt Rs m205407 50.5%   
Total assets Rs m2,75611,535 23.9%  
Interest coverage x1.211.2 10.8%   
Debt to equity ratio x0.20 512.2%  
Sales to assets ratio x0.80.7 122.5%   
Return on assets %4.47.6 58.7%  
Return on equity %-0.38.8 -3.5%  
Return on capital %14.212.7 111.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m335,618 0.6%   
Fx outflow Rs m21,225 0.1%   
Net fx Rs m324,394 0.7%   
CASH FLOW
From Operations Rs m264343 76.9%  
From Investments Rs m-93-78 120.3%  
From Financial Activity Rs m-171-249 68.5%  
Net Cashflow Rs m030 -0.7%  

Share Holding

Indian Promoters % 70.6 35.0 201.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 22.0 -  
FIIs % 0.0 15.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.4 65.0 45.2%  
Shareholders   7,055 40,758 17.3%  
Pledged promoter(s) holding % 44.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ANG LIFESCIENCES INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ANG LIFESCIENCES INDIA vs BLISS GVS PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ANG LIFESCIENCES INDIA vs BLISS GVS PHARMA Share Price Performance

Period ANG LIFESCIENCES INDIA BLISS GVS PHARMA S&P BSE HEALTHCARE
1-Day -3.74% -1.31% 1.18%
1-Month -29.30% -9.12% -0.75%
1-Year -41.49% 58.26% 61.82%
3-Year CAGR 9.52% 3.89% 18.16%
5-Year CAGR 19.50% -8.75% 19.79%

* Compound Annual Growth Rate

Here are more details on the ANG LIFESCIENCES INDIA share price and the BLISS GVS PHARMA share price.

Moving on to shareholding structures...

The promoters of ANG LIFESCIENCES INDIA hold a 70.6% stake in the company. In case of BLISS GVS PHARMA the stake stands at 35.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ANG LIFESCIENCES INDIA and the shareholding pattern of BLISS GVS PHARMA.

Finally, a word on dividends...

In the most recent financial year, ANG LIFESCIENCES INDIA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

BLISS GVS PHARMA paid Rs 0.5, and its dividend payout ratio stood at 6.8%.

You may visit here to review the dividend history of ANG LIFESCIENCES INDIA, and the dividend history of BLISS GVS PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.